{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:39:19Z","timestamp":1761547159924,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thoracic.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.thorsurg.2020.08.004","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T17:25:42Z","timestamp":1599931542000},"page":"461-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"30","author":[{"given":"Laura L.","family":"Donahoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.004_bib1","first-page":"402","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"10026","key":"10.1016\/j.thorsurg.2020.08.004_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"issue":"31","key":"10.1016\/j.thorsurg.2020.08.004_bib3","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2017.72.9012","article-title":"Nintedanib plus pemetrexed\/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-meso trial","volume":"35","author":"Grosso","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"28","key":"10.1016\/j.thorsurg.2020.08.004_bib4","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"van Meerbeeck","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.thorsurg.2020.08.004_bib5","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.004_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","article-title":"Malignant mesothelioma in situ: morphologic features and clinical outcome","volume":"33","author":"Churg","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fonc.2020.00187","article-title":"Immunotherapy in malignant pleural mesothelioma","volume":"10","author":"de Gooijer","year":"2020","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.004_bib8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(17)30446-1","article-title":"Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Maio","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.004_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S2213-2600(18)30151-6","article-title":"Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study","volume":"6","author":"Calabr\u00f2","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.004_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(18)30765-4","article-title":"Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial","volume":"20","author":"Scherpereel","year":"2019","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.thorsurg.2020.08.004_bib11","first-page":"4490","article-title":"Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors","volume":"63","author":"Nowak","year":"2003","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.21037\/tlcr.2017.06.03","article-title":"Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma","volume":"6","author":"Wu","year":"2017","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.004_bib13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"29","key":"10.1016\/j.thorsurg.2020.08.004_bib14","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.004_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jtcvs.2013.01.039","article-title":"The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11\u201314, 2012, Boston, Mass","volume":"145","author":"Rusch","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"13","key":"10.1016\/j.thorsurg.2020.08.004_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.004_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.21037\/tlcr.2018.07.07","article-title":"Extrapleural pneumonectomy: still indicated?","volume":"7","author":"Domen","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.004_bib18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jtho.2019.04.029","article-title":"A\u00a0proposed system toward standardizing surgical-based treatments for malignant pleural mesothelioma, from the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce","volume":"14","author":"Friedberg","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.004_bib19","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jtho.2018.04.032","article-title":"A\u00a0phase I trial of surgical resection and intraoperative hyperthermic cisplatin and gemcitabine for pleural mesothelioma","volume":"13","author":"Burt","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.004_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtcvs.2014.03.011","article-title":"Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality","volume":"148","author":"Burt","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"10","key":"10.1016\/j.thorsurg.2020.08.004_bib21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","article-title":"Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population","volume":"5","author":"Flores","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.004_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.31.1.15","article-title":"Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients","volume":"31","author":"Butchart","year":"1976","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejcts.2009.07.032","article-title":"Three decades of experience in the surgical multi-modality management of pleural mesothelioma","volume":"37","author":"Luckraz","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.004_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","article-title":"A\u00a0phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"122","author":"Rusch","year":"2001","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0360-3016(02)04150-0","article-title":"Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation","volume":"55","author":"Forster","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.004_bib26","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.004_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","article-title":"Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"8","author":"Gomez","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.004_bib28","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","article-title":"Radiotherapy for the treatment of malignant pleural mesothelioma","volume":"18","author":"de Perrot","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.004_bib29","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib30","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.004_bib31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","article-title":"Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial","volume":"36","author":"Van Schil","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2407-13-22","article-title":"Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma","volume":"13","author":"Federico","year":"2013","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10147-015-0925-1","volume":"21","author":"Hasegawa","year":"2016","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.004_bib34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ejcts\/ezy385","article-title":"Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy","volume":"55","author":"Frick","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.004_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)36577-8","article-title":"The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial","volume":"102","author":"Rusch","year":"1991","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib37","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(11)70307-2","article-title":"The MARS feasibility trial: conclusions not supported by data","volume":"12","author":"Weder","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.004_bib38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","article-title":"A\u00a0systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma","volume":"83","author":"Cao","year":"2014","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.21037\/jtd.2019.02.54","article-title":"Pathological evaluation of the visceral pleura in the radical pleurectomy\/decortication for malignant pleural mesothelioma patients","volume":"11","author":"Kobayashi","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.004_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5","article-title":"Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: prognosis and staging","volume":"72","author":"Boutin","year":"1993","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.004_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5223(96)70342-2","article-title":"The importance of surgical staging in the treatment of malignant pleural mesothelioma","volume":"111","author":"Rusch","year":"1996","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.lungcan.2019.03.026","article-title":"Lymphangitic carcinomatosis: a common radiographic manifestation of local failure following extended pleurectomy\/decortication in patients with malignant pleural mesothelioma","volume":"132","author":"Berger","year":"2019","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.004_bib43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/his.14105","article-title":"Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma","author":"Bilecz","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.12651","article-title":"Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival","author":"Quetel","year":"2020","journal-title":"Mol Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0277-5379(89)90266-6","article-title":"Radiation sensitivity of human lung cancer cell lines","volume":"25","author":"Carmichael","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"18","key":"10.1016\/j.thorsurg.2020.08.004_bib47","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1158\/1078-0432.CCR-17-0438","article-title":"In situ vaccination after accelerated hypofractionated radiation and surgery in a mesothelioma mouse model","volume":"23","author":"De La Maza","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A\u00a0feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the \"SMART\" approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ejcts\/ezw074","article-title":"Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?","volume":"50","author":"Mordant","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.004_bib50","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1634\/theoncologist.2018-0501","article-title":"Systemic therapy use and outcomes after relapse from preoperative radiation and extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"24","author":"Soldera","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.004_bib51","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01428-2016","article-title":"Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma","volume":"49","author":"de Perrot","year":"2017","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.004_bib52","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.athoracsur.2013.02.048","article-title":"Use of the posterior pericardium to cover the bronchial stump after right extrapleural pneumonectomy","volume":"96","author":"de Perrot","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2020.08.004_bib53","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.004_bib54","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.004_bib55","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Immunological mechanisms responsible for radiation-induced abscopal effect","volume":"39","author":"Rodr\u00edguez-Ruiz","year":"2018","journal-title":"Trends Immunol"},{"issue":"7652","key":"10.1016\/j.thorsurg.2020.08.004_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-Cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.004_bib57","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jtcvs.2019.10.122","article-title":"Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma","volume":"159","author":"de Perrot","year":"2019","journal-title":"J\u00a0Thorac Cardiovasc Surg"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412720300669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412720300669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:32:59Z","timestamp":1761546779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412720300669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1547412720300669"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.004","relation":{},"ISSN":["1547-4127"],"issn-type":[{"type":"print","value":"1547-4127"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}